Science

Chemiluminescence immunoassays support diagnosis of Alzheimer’s disease

EUROIMMUN chemiluminescence immunoassays (ChLIA) for Alzheimer’s disease (AD) biomarkers provide reliable analytical and clinical performance, as demonstrated in two newly published studies performed in a collaboration between researchers at EUROIMMUN and the Memory Clinic of the University Hospital Magdeburg, Germany. Measurement of the four core biomarkers beta-amyloid (Aβ) 1-40, Aβ1-42, total tau and tau phosphorylated

Products

Antibody testing reduces dengue vaccination risk

As the COVID-19 pandemic has recently demonstrated, vaccinations are one of the most important and effective preventive measures in medicine for the protection against an infectious disease. Dengue fever is one of the most common infectious diseases worldwide, but often underestimated. Dengue fever is caused by dengue virus (DENV) which is, among others, spread to

Scroll to Top